Home / Conferences / Medicines for Europe 16th Biosimilar Medicines Conference

Medicines for Europe 16th Biosimilar Medicines Conference Posted 09/02/2018

16th Biosimilar Medicines Conference – Biosimilar Medicines: Unlocking the Full Potential of Biologics
26−27 April 2018
Grange Tower Bridge Hotel
London, UK

On 26 and 27 April 2018, London will host the 16th Biosimilar Medicines Conference. This year’s flagship event will gather top EU and global regulators, officials, healthcare actors as well as industry leaders, to foster open exchange and debate on the role of the biosimilar medicines sector in ‘Biosimilar Medicines: Unlocking the Full Potential of Biologics’.

Over two days, participants will dive into a dynamic programme – a crossroads between technical, scientific, market discussions and the overarching healthcare policy agenda.

With 15 years of experience sharing on scientific assessment, regulatory approval and the introduction of biosimilar medicines in clinical practice, this conference will take us to new uncharted waters in preparing for this new era.

Join us for what promises to be an unprecedented edition of the Biosimilar Medicines Conference and contribute to shaping an environment where patient care pathways and access to standards of care are made easier thanks to the value that biosimilar medicines bring to healthcare systems.


Generics News Research General


Biosimilars News Research General